ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Up – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN) gapped up before the market opened on Monday . The stock had previously closed at $18.74, but opened at $19.46. ChronoScale Corporation Common Stock shares last traded at $17.67, with a volume of 40,726 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 24th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus target price of $6.00.

ChronoScale Corporation Common Stock Trading Down 3.4%

The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.06. The firm has a 50-day moving average price of $21.91 and a 200-day moving average price of $16.19. The company has a market capitalization of $2.64 billion, a price-to-earnings ratio of -3.36 and a beta of 1.00.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The firm had revenue of $18.40 million for the quarter. As a group, sell-side analysts predict that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CHRN. Roble Belko & Company Inc lifted its position in ChronoScale Corporation Common Stock by 104.5% in the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after buying an additional 1,195 shares in the last quarter. J.Safra Asset Management Corp purchased a new position in shares of ChronoScale Corporation Common Stock during the 2nd quarter valued at $48,000. Virtu Financial LLC purchased a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter valued at $57,000. Shay Capital LLC acquired a new position in shares of ChronoScale Corporation Common Stock in the third quarter worth $67,000. Finally, Osbon Capital Management LLC acquired a new position in shares of ChronoScale Corporation Common Stock in the second quarter worth $81,000. Hedge funds and other institutional investors own 6.42% of the company’s stock.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.